文献速递药物不良反应与药物警戒

加纳患者对药品不良反应报告的看法:一项横断面研究

Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
PubMed 文献 · Drug Saf · 2017-01-01

该研究于2016年8月25日至9月20日在加纳城市和农村两家社区药房以便利抽样选取442名18岁及以上患者进行面对面问卷调查,分析纳入434人(86.7%)。结果显示患者对药品不良反应报告持积极态度且认知较好,报告动机包括期望获取额外信息、分享经历及促进用药安全。

要点

  • 81.6%受访者知晓国家药物警戒中心存在,49.5%知晓患者可直接报告药品不良反应。
  • 46.3%受访者曾发生药品不良反应,其中53.2%向医务人员报告,36.9%因停药而未报告。
  • 患者报告三大原因:期望额外信息(92.4%)、分享经历(91.7%)、期望中心告知他人(88.0%)。

核心结论

  • 患者对向国家药物警戒中心报告药品不良反应持积极态度且认知良好,报告动机包括期望获取额外信息和促进用药安全。

研究设计与样本

  • 横断面研究,采用面对面访谈问卷,于2016年8月25日至9月20日以便利抽样从加纳城市和农村两家社区药房选取442名18岁及以上患者,分析纳入434人(86.7%)。

主要发现

  • 81.6%受访者知晓国家药物警戒中心存在,49.5%知晓患者可直接报告药品不良反应。
  • 46.3%受访者曾发生药品不良反应,其中53.2%向医务人员报告,36.9%因停药而未报告。
  • 患者报告三大原因:期望额外信息(92.4%)、分享经历(91.7%)、期望中心告知他人可能的不良反应(88.0%)。
  • 患者认为报告有助于研究/知识(96.5%)和改善用药安全(96.5%)。
  • 患者报告行为受报告可能后果、他人影响和报告便利性影响。

临床怎么用

  • 可通过定期公众宣传活动强调药品不良反应报告的重要性,并向患者提供及时反馈以维持其积极报告态度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Recent efforts to introduce direct patient reporting into pharmacovigilance systems have proved that patient reports contribute significantly to medicine safety, but there is a paucity of information relating to patients' perspectives regarding adverse drug reaction reporting in developing countries. OBJECTIVE: The objective of this study was to explore patients' knowledge, attitudes, behaviours and opinions on spontaneous adverse drug reaction reporting in Ghana. METHODS: A cross-sectional study using questionnaires administered through face-to-face interviews was carried out from 25 August, 2016 to 20 September, 2016 with 442 patients aged 18 years and above selected by convenience sampling from two community pharmacies in urban and rural Ghana. Reasons and opinions on patients' reporting on adverse drug reactions were surveyed using a 5-point Likert scale. The Pearson chi-square test was used to determine associations between background variables and responses on knowledge of adverse drug reaction reporting. RESULTS: Responses from 434 patients (86.7%) were included in the analysis. Among those interviewed, there was a high level of awareness regarding the existence of the National Pharmacovigilance Centre (81.6%). Approximately half of the respondents (49.5%) were aware that patients were able to report adverse drug reactions associated with medicinal products directly to the National Pharmacovigilance Centre. Of the respondents, 46.3% stated that they had an adverse drug reaction to their medicines in the past; of these, 53.2% reported to healthcare professionals and 36.9% failed to report because they stopped their medication. The three main reasons for patients' reporting were desire for extra information (92.4%), desire to share experiences with other people (91.7%) and expectation for the National Pharmacovigilance Centre to inform others about the possible adverse drug reactions (88.0%). Patients' opinions were to contribute to research/knowledge (96.5%) and improvements in drug safety (96.5%). Patients' behaviour towards adverse drug reaction reporting was affected by the likely consequences of reporting, influence of others and the ease of reporting. CONCLUSION: Patients have a positive attitude and good knowledge on adverse drug reaction reporting to the National Pharmacovigilance Centre and report because they expect extra information and to contribute to drug safety. Patients' positive attitude towards adverse drug reaction reporting could be sustained by hosting periodic public awareness campaigns addressing the importance of adverse drug reaction reporting and by providing timely feedback to patients on regulatory decisions taken as a result of the reports that they submitted.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Sabblah GT, Darko DM, Mogtari H, et al. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana. Drug Saf. 2017. PMID: 28653291. doi:10.1007/s40264-017-0563-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。